Google Alert - diet

News 1 new result for diet

Orexigen To Renew Development Of Contrave Diet Drug Wall Street Journal Orexigen Therapeutics Inc. (OREX) signaled Tuesday it would renew development of its experimental diet drug Contrave after the US Food and Drug Administration told the company it could approve Contrave if an interim analysis meets specified criteria on ... See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.